A monoclonal antibody against KCNK9 K+ channel extracellular domain inhibits tumour growth and metastasis
The potassium channel KCNK9 mediates important biological processes and is often overexpressed in breast and lung cancers. In this study, the authors developed a specific monoclonal antibody against the extracellular domain of KCNK9 and show that it inhibits cancer growth and metastasis in vivothrou...
Guardado en:
Autores principales: | Han Sun, Liqun Luo, Bachchu Lal, Xinrong Ma, Lieping Chen, Christine L. Hann, Amy M. Fulton, Daniel J. Leahy, John Laterra, Min Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/621136ed5d044eb9bc72178de246e111 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Concepts of extracellular matrix remodelling in tumour progression and metastasis
por: Juliane Winkler, et al.
Publicado: (2020) -
ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling
por: Yuan He, et al.
Publicado: (2021) -
Development and characterization of a monoclonal antibody blocking human TRPM4 channel
por: See Wee Low, et al.
Publicado: (2021) -
Common variants in KCNK5 and FHL5 genes contributed to the susceptibility of migraine without aura in Han Chinese population
por: Zhao Jiang, et al.
Publicado: (2021) -
Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis
por: Shu-Yi Yin, et al.
Publicado: (2016)